
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| IGPK | -81.73% | -86.23% | -32.71% | -100% |
| S&P | +13.95% | +78.35% | +12.25% | +431% |
Integrated Cannabis Solutions, Inc. is a development stage company, which focuses on the growing and processing of hemp in the United States. The firm intends to sell processed material in the form of Cannabidiol (CBD) or isolate to manufacturers or pharmaceutical companies for their manufacture, distribution, and sale of CBD related products, such as edibles for human consumption, vitamins, multi-vitamins, and topical products for human use such as oils, tinctures, creams, oils and salves, and vaping liquids. It also aims to promote and assist in the establishment of a co-op with local farmers for establishing a consistent supply of biomass. The company was founded on October 9, 1995 and is headquartered in West Palm Beach, FL.
No news articles found for Integrated Cannabis Solutions.
| Q1 2025 | YOY Change | |
|---|---|---|
| Revenue | $22.42M | -1.5% |
| Gross Profit | $549.81K | -23.4% |
| Gross Margin | 2.45% | -0.7% |
| Market Cap | $9.76M | -10.8% |
| Net Income | $135.89K | -62.9% |
| EBITDA | $135.89K | -62.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q1 2025 | YOY Change | |
|---|---|---|
| Net Cash | $4.26M | 8.9% |
| Accounts Receivable | $699.12K | 24.5% |
| Inventory | 0 | 0.0% |
| Q1 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $0.00K | 0.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Return On Assets | 3.71% | 0.0% |
| Return On Invested Capital | -40.90% | -63.0% |
| Q1 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $322.48K | 0.0% |
| Operating Free Cash Flow | $322.48K | 196.7% |
| Metric | Q1 2024 | Q2 2024 | YoY Change | ||
|---|---|---|---|---|---|
| Price to Earnings | 10.83 | 15.60 | - | ||
| Price to Book | -81.25 | 6.96 | 3.97 | 4.68 | - |
| Price to Sales | 1.24 | 0.76 | 0.33 | - | |
| Price to Tangible Book Value | -85.72 | 6.98 | 3.95 | 4.69 | - |
| Enterprise Value to EBITDA | 69.21 | 153.21 | 50.53 | 160.79 | - |
| Return on Equity | 91.6% | 44.8% | 3.7% | - | |
| Total Debt | $0.00K | $0.00K | $0.00K | $0.00K | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.